Vericel makes cell therapies and biologic products for knee cartilage repair and severe burn care. It last closed at $57.88 on Nov 17, up 0.70% on the day. The average 12-month price target from 3 analysts is $69.33 (+19.8% from the last close), with a high of $75.00 and a low of $65.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).
Each firm's latest rating on VCEL in the past 90 days
Average 12-month target
$69.33
▲ 19.8% upside
Based on 3 analysts who set a price target on VCEL in the past 90 days. The average target is $69.33, with a high of $75.00 and a low of $65.00, compared with the last close of $57.88.
Low $65.00Avg $69.33High $75.00
Blue marker: last close $57.88
Highest target$75.00
Average target$69.33
Lowest target$65.00
Latest rating changes
Stephens & Co.Maintained
Nov 10Buy$68
Truist SecuritiesTarget raised
Nov 9Buy$52 → $65
HC Wainwright & Co.Target raised
Nov 6Buy$72 → $75
Truist SecuritiesTarget lowered
Oct 14Buy$58 → $52
TD CowenMaintained
Jul 31Buy$58
Date
Firm
Action
Rating
Price target
Nov 10
Stephens & Co.
Maintained
Buy
$68
Nov 9
Truist Securities
Target raised
Buy
$52 → $65
Nov 6
HC Wainwright & Co.
Target raised
Buy
$72 → $75
Oct 14
Truist Securities
Target lowered
Buy
$58 → $52
Jul 31
TD Cowen
Maintained
Buy
$58
Loading…
Technical Analysis
VCEL · as of the Nov 17 close · updated after every close
Uptrend, overbought
The stock is 16% above its 20 day and 25% above its 50 day average. It is 32% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 75), overbought. The nearest support is the Pivot S1 at $57.28, and the nearest resistance the Pivot at $57.98.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 4.1%/day
Key levels
$59.7552 week high+3.2%
$59.75Swing high (Nov 11)+3.2%
$58.58Pivot R1+1.2%
$57.98Pivot+0.2%
$57.88Last close
$57.28Pivot S1−1.0%
$48.8520 day average−15.6%
$44.56Swing low (Jul 14)−23.0%
$44.03100 day average−23.9%
$43.5150 day average−24.8%
$39.62200 day average−31.5%
$28.9552 week low−50.0%
Indicators
RSI (14)
74.69
Overbought above 70
Overbought
MACD
4.65
Above its signal line
Bullish
Stochastic
88.6
Near the top of its range
Overbought
ADX (14)
39.5
Trending up
Williams %R
-9.2
Oversold below −80, overbought above −20
Overbought
CCI (20)
83.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+40.9%
Change over 10 sessions
Bullish
ATR (14)
$2.36
Typical daily range, 4.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchOverbought
VolatilityNormal, 6.9%/day
Key levels
$59.7552 week high+3.2%
$59.75Swing high (Nov 11)+3.2%
$58.58Pivot R1+1.2%
$57.98Pivot+0.2%
$57.88Last close
$57.28Pivot S1−1.0%
$48.8520 day average−15.6%
$44.56Swing low (Jul 14)−23.0%
$44.03100 day average−23.9%
$43.5150 day average−24.8%
$39.62200 day average−31.5%
$28.9552 week low−50.0%
Indicators
RSI (14)
75.48
Overbought above 70
Overbought
MACD
3.39
Above its signal line
Bullish
Stochastic
91.3
Near the top of its range
Overbought
ADX (14)
32.3
Trending up
Williams %R
-8.3
Oversold below −80, overbought above −20
Overbought
CCI (20)
215.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+51.0%
Change over 10 sessions
Bullish
ATR (14)
$4.01
Typical daily range, 6.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for VCEL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VCEL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow VCEL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How VCEL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VCEL is in one of them and how their past VCEL trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Vericel
Vericel is a company in Burlington, Massachusetts that makes cell therapy and specialty biologic products for sports medicine and severe burn care. Its MACI product is an implant made from a patient's own cells that orthopedic surgeons use to repair knee cartilage. Epicel is a permanent skin replacement for severe burns, and NexoBrid is a product applied to burns to remove damaged tissue. Its customers include orthopedic surgeons and burn centers in the United States.